Atrial Fibrillation Market to Exhibit Skyrocketing Expansion During 2022-2028 | AtriCure, Inc., Biosense Webster, Inc., Boehringer Ingelheim GmbH

𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 released a new market study on 2022-2028 Atrial Fibrillation Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The global research report delivers an in-depth watch on leading competitors with strategic analysis, small and macro business trends and eventualities, valuation analysis and a holistic summary within the forecast amount. Its knowledge and in-depth reports specializing in primary and secondary drivers, market share, leading segments, and geographical analysis. Further, key players, major collaborations, merger & acquisitions of trending innovation and business policies reviewed within the report. The report contains basic, secondary and advanced data referring to international standing and trend, size, share, growth, trends analysis, section, and forecasts.

Request Here For PDF Brochure : https://www.coherentmarketinsights.com/insight/request-pdf/205

Market Overview:

Atrial fibrillation is probably one of the more common forms of cardiac arrhythmias, this is when irregular heart rhythms are caused by the atrial fibrillation or the 'ibrillation' of the atrial cells. Atrial fibrillation occurs when the ventricular pressure of the heart is too low or the heart is beating too fast for the ventricular muscles to handle. This causes the ventricular muscle to contract very quickly and leads to a heart rhythm that is very irregular and can even be seen on an electrocardiogram. Atrial Fibrillation or the 'fibrillar fibrillations' is usually caused by many different factors. Some say that it can be hereditary, but it is also something that can happen suddenly and without any warning. Atrial fibrillation is usually characterized by shortness of breath, palpitations, dizziness, nausea, chest pain, diarrhea, and sweating.

Major Players are: AtriCure, Inc., Biosense Webster, Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, CardioFocus, Inc., Endoscopic Technologies, Inc., Sanofi Aventis, Inc., Johnson and Johnson Ltd., and Abbott Laboratories.

Key Market Drivers:

The growing prevalence of atrial fibrillation is primarily fueling growth of the atrial fibrillation market. According to the Centers for Disease Control and Prevention (CDC), approximately 2 percent of people younger than 65 years old have AFib, while about 9 percent of people ages 65 and older have it

The rise in the geriatric population is increasing prevalence of atrial fibrillation. This is another major factor augmenting growth of the market. According to the World Health Organization, by 2020, the number of people aged 60 years and older will outnumber children younger than 5 years. In 2050, 80% of older people will be living in low- and middle-income countries.

Covid-19 Impact Analysis

During the Covid-19 pandemic, there was high demand for atrial fibrillation as infected patients with cardiovascular disease are at high risk and vulnerable to multiple organ failures. Thus, the market of atrial fibrillation has witnessed strong growth during Covid -19 pandemic.

Have a look on Sample Version of Report: https://www.coherentmarketinsights.com/insight/request-sample/205

Key Takeaways:

The atrial fibrillation market is expected to exhibit a CAGR of XX % over the forecast period, owing to the increasing launch of AI-based diagnostic tests. For instance, in March 2021, the U.S. FDA has granted breakthrough device designation to Tempus Inc. for its ECG Analysis Platform. It was developed in collaboration with Geisinger, the artificial intelligence (AI)-powered platform helps clinicians identify patients at increased risk of developing atrial fibrillation (AF) or atrial flutter.

North America is expected to witness strong growth in the near future owing to the high prevalence of atrial fibrillation in the region. According to the Centers for Disease Control and Prevention, more than 454,000 hospitalizations with AFib as the primary diagnosis happen each year in the United States. The condition contributes to about 158,000 deaths each year.

How Will The Atrial Fibrillation Market Report Be Beneficial?

This report will be a valuable assessment for new startups who wish to enter the Atrial Fibrillation Market, as it will not just provide the current market trends but also predict the future trends. You will get a look at the customised market segments according to geographical regions, country or even different combinations of manufacturers in the market.

Direct Purchase This Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/205

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

𝐀𝐛𝐨𝐮𝐭 𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.